Study shows that psilocybin promotes a selective reorganization of brain connections, strengthening sensory and subcortical pathways and weakening feedback circuits between cortical regions

NBER study indicates that access to recreational cannabis, through the opening of dispensaries, is associated with a reduction in suicide rates among older adults in the US

Trump states he does not intend to use medical cannabis, but acknowledges that the substance can be an alternative to opioids and necessary for many patients.

Research shows how the year-end can intensify emotional triggers and increase substance use, reinforcing the importance of care and empathy during parties

France has raised the fine for drug use to 500 euros, sparking debate on cannabis policy and regulatory models in the country

Despite the executive order signed by Donald Trump, cannabis continues without federal legalization in the US, keeping the market dependent on state laws

Lucy is a virtual patient created with artificial intelligence to assist in the training of therapists in psychedelic therapies, such as MDMA and psilocybin

The use of cannabis does not automatically prevent blood donation, but some precautions are essential to ensure safety for the donor and the process.

Planning to travel at the end of the year and using medicinal cannabis? Learn about the required documents, how to transport the medication, and what precautions to take in Brazil and abroad.

Bill regulating psilocybin therapy advances in New Jersey, allowing supervised use of the substance for therapeutic purposes

Proposal creates a new regulatory framework, authorizes sales in liquor stores, and reignites criticism over the legislative process in New Jersey.

Authorities in Oregon, US, remove hemp pre-rolls from the market after detecting THC levels above the allowed limit

Study points to an increase in cases of cannabinoid hyperemesis syndrome, a condition associated with prolonged cannabis use and characterized by intense nausea and vomiting

The event brings together health, science, industry, and agribusiness experts to discuss advances, regulatory challenges, and the future of medicinal cannabis and industrial hemp in Brazil.

National survey shows unprecedented reversal: consumption decreases among boys and nearly quadruples among girls aged 14 to 17 in ten years

Letter brings together experts from across the country and includes UFLA participation

Preclinical study suggests CBD may reduce intestinal spasms and diarrhea, with a direct effect on gastrointestinal motility

While PubMed records a record number of publications, a JAMA review questions the robustness of the evidence; understand the current research landscape on cannabis

At the request of the attorney general, the Florida Supreme Court is evaluating the constitutionality of a new initiative seeking to legalize cannabis in 2026

Survey in the United Kingdom indicates that the majority of patients undergoing medical cannabis treatment report significant improvement in quality of life and daily activities

New EFSA opinion brings more scientific clarity on Δ8-THC in hemp-derived foods, contributing to consumer safety and regulatory advancement in the sector

Move from Schedule I to Schedule III could unlock research, ease fiscal obstacles, and impact state markets

Although less famous than CBD and THC, cannabinol stands out for its sedative properties and promising medicinal applications in the treatment of insomnia and inflammation

Rômison Rodrigues Mota leaves the position after a request for review delays the norm's vote; the topic will return to the regulatory agenda for 2026-2027

Partnership with startup Buds INC investigates the physical and chemical properties of the material to extend the lifespan and resistance of recyclable products

New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.

A group of 58 specialists from public and private universities advocates for evidence-based regulations for the cultivation and regulation of cannabis in Brazil

Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification

Study shows that cannabis extract can reduce chronic lower back pain and improve the quality of life of patients